“Joel brought his wealth of experience and expertise to the Glaucoma Service as Vice Chair & Director. It was a breath of fresh air to work with someone with such professionalism and such congeniality towards patients. I had the honor of working with Joel on an almost daily basis and it only enhanced my abilities to provide the best service to our patients and colleagues. I would work with Joel again, if the opportunity arose.”
Activity
-
As someone who attended camp as a kid but was generally more interested in air conditioning than outdoor activities (a consequence of being prone to…
As someone who attended camp as a kid but was generally more interested in air conditioning than outdoor activities (a consequence of being prone to…
Liked by Joel S. Schuman
-
Life in the Pediatric Ophthalmology lane... Love working with Caitlin Jomoc, OD and techs extraordinaire Sarah Midura & Devin Shea who make an…
Life in the Pediatric Ophthalmology lane... Love working with Caitlin Jomoc, OD and techs extraordinaire Sarah Midura & Devin Shea who make an…
Liked by Joel S. Schuman
-
This is what symposia is about - collaboration and advances. This pic captures just that, 3 people thinking out loud, leveraging a 250Khz OCT engine…
This is what symposia is about - collaboration and advances. This pic captures just that, 3 people thinking out loud, leveraging a 250Khz OCT engine…
Liked by Joel S. Schuman
Experience & Education
Licenses & Certifications
Publications
-
reproducibility of in-vivo oct measured three-dimensional human lamina cribrosa microarchitecture
plos one
See publicationabstract purpose to determine the reproducibility of automated segmentation of the three-dimensional (3d) lamina cribrosa (lc) microarchitecture scanned in-vivo using optical coherence tomography (oct). methods thirty-nine eyes (8 healthy, 19 glaucoma suspects and 12 glaucoma) from 49 subjects were scanned twice using swept-source (ss−) oct in a 3.5×3.5×3.64 mm (400×400×896 pixels) volume centered on the optic nerve head, with the focus readjusted after each scan. the lc was automatically…
abstract purpose to determine the reproducibility of automated segmentation of the three-dimensional (3d) lamina cribrosa (lc) microarchitecture scanned in-vivo using optical coherence tomography (oct). methods thirty-nine eyes (8 healthy, 19 glaucoma suspects and 12 glaucoma) from 49 subjects were scanned twice using swept-source (ss−) oct in a 3.5×3.5×3.64 mm (400×400×896 pixels) volume centered on the optic nerve head, with the focus readjusted after each scan. the lc was automatically segmented and analyzed for microarchitectural parameters, including pore diameter, pore diameter standard deviation (sd), pore aspect ratio, pore area, beam thickness, beam thickness sd, and beam thickness to pore diameter ratio. reproducibility of the parameters was assessed by computing the imprecision of the parameters between the scans. results the automated segmentation demonstrated excellent reproducibility. all lc microarchitecture parameters had an imprecision of less or equal to 4.2%. there was little variability in imprecision with respect to diagnostic category, although the method tends to show higher imprecision amongst healthy subjects. conclusion the proposed automated segmentation of the lc demonstrated high reproducibility for 3d lc parameters. this segmentation analysis tool will be useful for in-vivo studies of the lc.
-
Inflammatory response to intravitreal injection of gold nanorods
British Journal of Ophthalmology
Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets…Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets (T cells, myeloid cells, macrophages, neutrophils). Generalised estimation equations were used to compare cell counts between groups.
Results: PSS-AuNRs and Ab-AuNRs were visualised in the vitreous 30 min and 24 h post-injection with OCT. At 24 h, a statistically significant increase in leukocytes, comprised primarily of neutrophils, was observed in eyes that received either AuNR in comparison to eyes that received saline. The accumulation of leukocytes was equal in eyes given PSS-AuNR or Ab-AuNR. Endotoxin-resistant C3H/HeJ mice also showed ocular inflammation after injection with AuNRs, indicating that the inflammatory response was not due to lipopolysaccharide contamination of AuNRs.
Conclusions: Although AuNRs can be visualised in the eye using OCT, they can induce ocular inflammation, which limits their use as a contrast agent.Other authorsSee publication -
Inflammatory response to intravitreal injection of gold nanorods
British Journal of Ophthalmology
Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets…Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets (T cells, myeloid cells, macrophages, neutrophils). Generalised estimation equations were used to compare cell counts between groups.
Results: PSS-AuNRs and Ab-AuNRs were visualised in the vitreous 30 min and 24 h post-injection with OCT. At 24 h, a statistically significant increase in leukocytes, comprised primarily of neutrophils, was observed in eyes that received either AuNR in comparison to eyes that received saline. The accumulation of leukocytes was equal in eyes given PSS-AuNR or Ab-AuNR. Endotoxin-resistant C3H/HeJ mice also showed ocular inflammation after injection with AuNRs, indicating that the inflammatory response was not due to lipopolysaccharide contamination of AuNRs.
Conclusions: Although AuNRs can be visualised in the eye using OCT, they can induce ocular inflammation, which limits their use as a contrast agent.Other authorsSee publication -
Optical coherence tomography: future trends for imaging in glaucoma
Optom Vis Sci
Optical coherence tomography captures a major role in clinical assessment in eye care. Innovative hardware and software improvements in the technology would further enhance its usefulness. In this review, we present several promising initiatives currently in development or early phase of assessment that we expect to have a future impact on optical coherence tomography.
Other authorsSee publication -
Variation in optical coherence tomography signal quality as an indicator of retinal nerve fibre layer segmentation error
Br J Ophthalmol
Commercial optical coherence tomography (OCT) systems use global signal quality indices to quantify scan quality. Signal quality can vary throughout a scan, contributing to local retinal nerve fibre layer segmentation errors (SegE). The purpose of this study was to develop an automated method, using local scan quality, to predict SegE.
Other authorsSee publication -
Clinical application of MRI in ophthalmology.
NMR Biomed.
MRI has long been applied to clinical medical and neurological cases for the structural assessment of tissues as well as their physiological and functional needs and processes. These uses are at a variety of developmental stages in ophthalmology, from common use of clinical structural assessment for neuro-ophthalmology and evaluation of space-occupying lesions to the beginning stages of experimentally measuring functional activation of specific layers within the retina and measurement of…
MRI has long been applied to clinical medical and neurological cases for the structural assessment of tissues as well as their physiological and functional needs and processes. These uses are at a variety of developmental stages in ophthalmology, from common use of clinical structural assessment for neuro-ophthalmology and evaluation of space-occupying lesions to the beginning stages of experimentally measuring functional activation of specific layers within the retina and measurement of physiological oxygen responses. New MRI methodologies, such as the use of orbital coils and Gd-DTPA image enhancement, have been researched, developed, and validated in the eye, opening new possibilities for this technology to enter the clinic. This review aims to summarize the clinical ophthalmological uses of MRI, focusing on the current use of the technology and future applications.
Other authorsSee publication
Patents
-
Inhibition of proliferation and fibrotic response of activated corneal stromal cells
Issued USPTO 08815946
See patentProvided herein are methods of preventing a fibrotic response and/or scarring in a wound, comprising administering to a subject a composition comprising an amount of an amide or ester of an alpha-ketoalkanoic acid effective to inhibit a proliferative and/or fibrotic response in the wound. In one instance, the wound is to a subject's cornea, such as a wound resulting from refractive surgery. In one embodiment, the amide or ester of an alpha-ketoalkanoic acid is ethyl pyruvate.
-
Method of Using Matrix Metalloproteinase Inhibitors in Filtering Blebs Following Glaucoma Filtering Surgery and in the Treatment of Ischemic Damage to the Retina and Optic Nerve
Issued US 6503892
This invention provides a method of inhibiting, preventing, and/or treating conjunctival filtering bleb leaks that may occur following glaucoma filtering surgery by administering Matrix Metalloproteinase inhibitors to glaucoma patients who have undergone such surgery. The invention additionally includes a method of using Matrix Metalloproteinase inhibitors to inhibit, prevent, and/or treat ischemic damage to the retina and optic nerve in patients in need of such treatment.
Other inventors
Projects
Organizations
-
Drexel University School of Biomedical Engineering, Science and Health Systems
Professor of Biomedical Engineering
- Present -
Wills Eye Hospital
Kenneth L. Roper, MD Endowed Chair Vice Chair for Research Innovation Vickie and Jack Farber Vision Research Center Co-Director, Glaucoma Service Wills Eye Hospital Professor, Department of Ophthalmology Sidney Kimmel Medical College at Thomas Jefferson University
- Present -
NYU
Professor and Chairman of Ophthalmology
-
Recommendations received
2 people have recommended Joel S.
Join now to viewMore activity by Joel S.
-
Today we celebrated the remarkable Residents and Fellows of the Wills Eye Class of 2026! Congratulations to all - we are wishing you the very best.
Today we celebrated the remarkable Residents and Fellows of the Wills Eye Class of 2026! Congratulations to all - we are wishing you the very best.
Liked by Joel S. Schuman
-
Wills Eye Hospital Ophthalmologist-in-Chief and Chief Executive Officer, Dr. Julia A. Haller, welcomes the newest class of residents with a…
Wills Eye Hospital Ophthalmologist-in-Chief and Chief Executive Officer, Dr. Julia A. Haller, welcomes the newest class of residents with a…
Liked by Joel S. Schuman
-
Thankful for the opportunity to give a remote talk from the United States at the Sulbra 2026 in Florianópolis. Neuro-Ophthalmolgical and retinal…
Thankful for the opportunity to give a remote talk from the United States at the Sulbra 2026 in Florianópolis. Neuro-Ophthalmolgical and retinal…
Liked by Joel S. Schuman
-
🚀 𝗪𝗲’𝗿𝗲 𝗵𝗶𝗿𝗶𝗻𝗴! 𝗖𝗼𝗺𝗲 𝗵𝗲𝗹𝗽 𝘂𝘀 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝗯𝗹𝗶𝗻𝗱𝗻𝗲𝘀𝘀 𝘄𝗶𝘁𝗵 𝗔𝗜. At AEYE Health, we’re building FDA-cleared…
🚀 𝗪𝗲’𝗿𝗲 𝗵𝗶𝗿𝗶𝗻𝗴! 𝗖𝗼𝗺𝗲 𝗵𝗲𝗹𝗽 𝘂𝘀 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝗯𝗹𝗶𝗻𝗱𝗻𝗲𝘀𝘀 𝘄𝗶𝘁𝗵 𝗔𝗜. At AEYE Health, we’re building FDA-cleared…
Liked by Joel S. Schuman
-
Leading up to graduation on June 26, we will be spotlighting Wills Eye Hospital's Class of 2026 🎓 Join us in congratulating Lily Farrell, MD, and…
Leading up to graduation on June 26, we will be spotlighting Wills Eye Hospital's Class of 2026 🎓 Join us in congratulating Lily Farrell, MD, and…
Liked by Joel S. Schuman
-
Today I had the opportunity to speak at an all-hands meeting as we launched *jazz hands please* Pride Month. I spoke about Christina Aguilera’s…
Today I had the opportunity to speak at an all-hands meeting as we launched *jazz hands please* Pride Month. I spoke about Christina Aguilera’s…
Liked by Joel S. Schuman
-
My heart is full after two days of celebrating Harvard Ophthalmology at the Annual Alumni meeting, connecting with friends new and old. I had the…
My heart is full after two days of celebrating Harvard Ophthalmology at the Annual Alumni meeting, connecting with friends new and old. I had the…
Liked by Joel S. Schuman
-
Our team at ECU Health Ophthalmology continues to grow. Since launching in 2023, we've been building a division of highly trained eye specialists…
Our team at ECU Health Ophthalmology continues to grow. Since launching in 2023, we've been building a division of highly trained eye specialists…
Liked by Joel S. Schuman
-
Very honored to receive this teaching award. One of the great joys of academic medicine is helping learners develop into confident physicians—and…
Very honored to receive this teaching award. One of the great joys of academic medicine is helping learners develop into confident physicians—and…
Liked by Joel S. Schuman
-
📣 Call for Abstracts | APOIS-KOS 2026 👁️ Where clinical insight meets innovation in ophthalmology As ophthalmology enters a new era shaped by 🤖…
📣 Call for Abstracts | APOIS-KOS 2026 👁️ Where clinical insight meets innovation in ophthalmology As ophthalmology enters a new era shaped by 🤖…
Liked by Joel S. Schuman
-
I am very happy for the new publication in Progress in Retinal and Eye Research, a highly top tier journal. Congrats to all authors and gratitude to…
I am very happy for the new publication in Progress in Retinal and Eye Research, a highly top tier journal. Congrats to all authors and gratitude to…
Liked by Joel S. Schuman
Other similar profiles
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content